Innova Captab

{
  "main_header": {
    "sid": 10039112,
    "name": "Innova Captab",
    "stock_name": "Innova Captab",
    "full_name": "Innova Captab Ltd",
    "name_url": "stocks-analysis/innova-captab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "685.00",
    "chg": 19.9,
    "chgp": "2.99%",
    "dir": 1,
    "prev_price": "665.10",
    "mcapval": "3,826.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544067",
    "symbol": "INNOVACAP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0DUT01020",
    "curr_date": "Mar 24",
    "curr_time": "",
    "bse_nse_vol": "23.23 k",
    "exc_status": "Active",
    "traded_date": "Mar 24, 2026",
    "traded_date_str": "2026 03 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innova-captab-10039112-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Innova Captab Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-by-marketsmojo-3902922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/InnovaCaptabLtd_mojoScore_3902922.png",
        "date": "2026-03-20 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3879220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/InnovaCaptabLtd_mojoScore_3879220.png",
        "date": "2026-03-09 10:10:02",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Innova Captab Ltd Falls to 52-Week Low of Rs.608.25 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-falls-to-52-week-low-of-rs60825-amidst-continued-downtrend-3865021",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/InnovaCaptabLtd_priceRelatedfactors_3865021.png",
        "date": "2026-03-02 13:13:20",
        "description": "Innova Captab Ltd’s stock reached a fresh 52-week low of Rs.608.25 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector peers and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3857891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3857891.png",
        "date": "2026-02-26 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3840967",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3840967.png",
        "date": "2026-02-15 10:10:07",
        "description": "Innova Captab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3820454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3820454.png",
        "date": "2026-02-04 10:10:04",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-shows-mild-recovery-amid-mixed-technical-signals-3817324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_technicaldot_3817324.png",
        "date": "2026-02-03 08:05:41",
        "description": "Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions."
      },
      {
        "title": "Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-reports-strong-quarterly-turnaround-amid-challenging-market-conditions-3804868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_fintrenddot_3804868.png",
        "date": "2026-01-27 08:00:24",
        "description": "Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3803154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_mojoScore_3803154.png",
        "date": "2026-01-24 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 492,
    "sid": "10039112",
    "stock_news_url": "https://www.marketsmojo.com/news/innova-captab-10039112"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Mar-2026",
      "details": "Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that official(s)/ representative(s) of the Company will be meeting and interacting with the Investors/Analysts (Participants) as per the attached detail.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Feb-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Pursuant to the Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that officials of the Company will be meeting Investors/ Analysts (Participants) as per the details attached.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Pursuant to Regulation 30 read with Schedule III (Part A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be attending the Investor Conference as per the details provided in intimation.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Innova Captab Ltd has declared <strong>20%</strong> dividend, ex-date: 30 Jan 26",
          "dt": "2026-01-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Innova Captab Ltd is Rated Sell by MarketsMOJO

2026-03-20 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Innova Captab Ltd is Rated Sell

2026-03-09 10:10:02

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Read full news article

Innova Captab Ltd Falls to 52-Week Low of Rs.608.25 Amidst Continued Downtrend

2026-03-02 13:13:20

Innova Captab Ltd’s stock reached a fresh 52-week low of Rs.608.25 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind sector peers and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-26 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 February 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-15 10:10:07

Innova Captab Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Innova Captab Ltd is Rated Sell

2026-02-04 10:10:04

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals

2026-02-03 08:05:41

Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions.

Read full news article

Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions

2026-01-27 08:00:24

Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance.

Read full news article

Innova Captab Ltd is Rated Sell

2026-01-24 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

View All News